Adeno-associated virus gene therapy for hemophilia B: a comparative appraisal of the licensed products

Wolfgang Miesbach, Glenn F. Pierce

Open source

DOI
10.3324/haematol.2026.301979
Published
2026-11-05
Container
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2026.301979,
  title = {Adeno-associated virus gene therapy for hemophilia B: a comparative appraisal of the licensed products},
  author = {Wolfgang Miesbach and Glenn F. Pierce},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2026.301979},
  url = {https://doi.org/10.3324/haematol.2026.301979}
}

RIS

TY  - JOUR
TI  - Adeno-associated virus gene therapy for hemophilia B: a comparative appraisal of the licensed products
AU  - Wolfgang Miesbach
AU  - Glenn F. Pierce
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2026.301979
UR  - https://doi.org/10.3324/haematol.2026.301979
ER  - 

APA

Miesbach, W., & Pierce, G. F. (2026). Adeno-associated virus gene therapy for hemophilia B: a comparative appraisal of the licensed products. Haematologica. https://doi.org/10.3324/haematol.2026.301979

Source records